Neurocrine reports 12-week results from phase IIb study of tardive dyskinesia candidate Jan. 13, 2014
AC Immune raises funds and initiates trial of vaccine candidate for Alzheimer's disease Jan. 13, 2014
Labrys Biologics begins two phase II studies of LBR-101 in chronic and episodic migraine Jan. 10, 2014
RSS